Click for best price
Chemotheraphy Induced Nausea Vomitting CINV Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 2431.4 million
|
Forecast Market size by 2029 |
US$ 2182.5 million
|
| Growth Rate |
CAGR of -1.5% |
Number of Pages |
119 Pages |
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.
This report aims to provide a comprehensive presentation of the global market for Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs. This report contains market size and forecasts of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in global, including the following market information:
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs companies in 2022 (%)
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at US$ 2431.4 million in 2022 and is projected to reach US$ 2182.5 million by 2029, at a CAGR of -1.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.
We surveyed the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segment Percentages, by Type, 2022 (%)
5-HT3 Inhibitors
NK1 Inhibitors
Others
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segment Percentages, by Application, 2022 (%)
Acute CINV
Delayed CINV
Breakthrough CINV
Others
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs revenues share in global market, 2022 (%)
Key companies Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, market overview.
Chapter 2: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 2431.4 million
|
| Forecast Market size by 2029 |
US$ 2182.5 million
|
| Growth Rate |
CAGR of -1.5% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Overall Market Size
2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size: 2022 VS 2029
2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players in Global Market
3.2 Top Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies Ranked by Revenue
3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Companies
3.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Companies
3.5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Markets, 2022 & 2029
4.1.2 5-HT3 Inhibitors
4.1.3 NK1 Inhibitors
4.1.4 Others
4.2 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue & Forecasts
4.2.1 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales & Forecasts
4.3.1 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2018-2023
4.3.2 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2024-2029
4.3.3 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2022 & 2029
5.1.2 Acute CINV
5.1.3 Delayed CINV
5.1.4 Breakthrough CINV
5.1.5 Others
5.2 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue & Forecasts
5.2.1 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2024-2029
5.2.3 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales & Forecasts
5.3.1 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2018-2023
5.3.2 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2024-2029
5.3.3 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue & Forecasts
6.2.1 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales & Forecasts
6.3.1 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2018-2023
6.3.2 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2024-2029
6.3.3 By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2029
6.4.2 By Country - North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2018-2029
6.4.3 US Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.4.4 Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.4.5 Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2018-2029
6.5.3 Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.5.4 France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.5.5 U.K. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.5.6 Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.5.7 Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.5.9 Benelux Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2018-2029
6.6.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.6.4 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.6.5 South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.6.7 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2029
6.7.2 By Country - South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2018-2029
6.7.3 Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.7.4 Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, 2018-2029
6.8.3 Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.8.4 Israel Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
6.8.6 UAE Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Heron Therapeutics
7.1.1 Heron Therapeutics Company Summary
7.1.2 Heron Therapeutics Business Overview
7.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Heron Therapeutics Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Eisai
7.3.1 Eisai Company Summary
7.3.2 Eisai Business Overview
7.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Eisai Key News & Latest Developments
7.4 Mundipharma
7.4.1 Mundipharma Company Summary
7.4.2 Mundipharma Business Overview
7.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Mundipharma Key News & Latest Developments
7.5 Qilu Pharma
7.5.1 Qilu Pharma Company Summary
7.5.2 Qilu Pharma Business Overview
7.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Qilu Pharma Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Teva Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.7.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Mylan
7.9.1 Mylan Company Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Mylan Key News & Latest Developments
7.10 Baxter
7.10.1 Baxter Company Summary
7.10.2 Baxter Business Overview
7.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Baxter Key News & Latest Developments
7.11 GSK
7.11.1 GSK Company Summary
7.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Business Overview
7.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.11.5 GSK Key News & Latest Developments
7.12 Helsinn
7.12.1 Helsinn Company Summary
7.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Business Overview
7.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Helsinn Key News & Latest Developments
7.13 Southwest Pharma
7.13.1 Southwest Pharma Company Summary
7.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Business Overview
7.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Southwest Pharma Key News & Latest Developments
7.14 Haisco
7.14.1 Haisco Company Summary
7.14.2 Haisco Business Overview
7.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Haisco Key News & Latest Developments
7.15 Sun Pharma
7.15.1 Sun Pharma Company Summary
7.15.2 Sun Pharma Business Overview
7.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Product Offerings
7.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Sun Pharma Key News & Latest Developments
8 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity, Analysis
8.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity, 2018-2029
8.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Supply Chain Analysis
10.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Value Chain
10.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Upstream Market
10.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs in Global Market
Table 2. Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Companies, (M Units), 2018-2023
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
Table 9. List of Global Tier 1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2018-2023
Table 15. By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2024-2029
Table 16. By Application ? Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2018-2023
Table 20. By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2024-2029
Table 21. By Region ? Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2018-2023
Table 25. By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), 2024-2029
Table 26. By Country - North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2018-2023
Table 29. By Country - North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2024-2029
Table 30. By Country - Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2018-2023
Table 33. By Country - Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2024-2029
Table 34. By Region - Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2018-2023
Table 37. By Region - Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2024-2029
Table 38. By Country - South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2018-2023
Table 41. By Country - South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2024-2029
Table 42. By Country - Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2018-2023
Table 45. By Country - Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (M Units), 2024-2029
Table 46. Heron Therapeutics Company Summary
Table 47. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 48. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Heron Therapeutics Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 52. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Eisai Company Summary
Table 55. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 56. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Eisai Key News & Latest Developments
Table 58. Mundipharma Company Summary
Table 59. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 60. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Mundipharma Key News & Latest Developments
Table 62. Qilu Pharma Company Summary
Table 63. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 64. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Qilu Pharma Key News & Latest Developments
Table 66. Teva Company Summary
Table 67. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 68. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Teva Key News & Latest Developments
Table 70. Novartis Company Summary
Table 71. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 72. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Novartis Key News & Latest Developments
Table 74. Roche Company Summary
Table 75. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 76. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Roche Key News & Latest Developments
Table 78. Mylan Company Summary
Table 79. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 80. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Mylan Key News & Latest Developments
Table 82. Baxter Company Summary
Table 83. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 84. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Baxter Key News & Latest Developments
Table 86. GSK Company Summary
Table 87. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 88. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. GSK Key News & Latest Developments
Table 90. Helsinn Company Summary
Table 91. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 92. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Helsinn Key News & Latest Developments
Table 94. Southwest Pharma Company Summary
Table 95. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 96. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Southwest Pharma Key News & Latest Developments
Table 98. Haisco Company Summary
Table 99. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 100. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Haisco Key News & Latest Developments
Table 102. Sun Pharma Company Summary
Table 103. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Offerings
Table 104. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Sun Pharma Key News & Latest Developments
Table 106. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity (M Units) of Key Manufacturers in Global Market, 2021-2023 (M Units)
Table 107. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production by Region, 2018-2023 (M Units)
Table 109. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production by Region, 2024-2029 (M Units)
Table 110. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Opportunities & Trends in Global Market
Table 111. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers in Global Market
Table 112. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints in Global Market
Table 113. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Raw Materials
Table 114. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Downstream
Table 116. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Downstream Clients in Global Market
Table 117. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type in 2022
Figure 2. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application in 2022
Figure 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Global Market: 2018-2029 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue in 2022
Figure 9. By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
Figure 23. US Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
Figure 28. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
Figure 37. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity (M Units), 2018-2029
Figure 53. The Percentage of Production Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Region, 2022 VS 2029
Figure 54. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Value Chain
Figure 55. Marketing Channels
